Pfizer to continue vaccine supply to even if files lawsuit: CEO to paper

(Reuters) - Pfizer will continue to supply its COVID-19 vaccine to , respecting its agreement with the European Commission, even if sues the company, the chief executive of the group's Italian unit said on Thursday.

"We do not intend to speculate on this, but we will continue to supply the vaccine as envisaged by the agreements with the European Commission," the CEO of Pfizer in , Paivi Kerkola, said in an interview with daily la Repubblica.

Kerkola said that the group's supply of vaccine to would be back to "regular" this week.

On Tuesday, asked the European Commission to take action against Pfizer over cuts to its COVID-19 vaccine deliveries, a day after had sent a formal warning letter to the U.S drug company calling on it to respect its contractual commitments after a slowdown in deliveries.

Last week Pfizer said it was temporarily slowing supplies to Europe to make manufacturing changes that would boost output.

Insurance Loans Mortgage Attorney Credit Lawyer

Kerkola said she believed that the group would be able to supply about 2 billion vaccine doses by the end of the year and that increases in production volume would be seen from mid-February.

Asked about the difference in vaccine prices Pfizer applied to different countries, the executive said prices remained confidential but the company used a "fair access" principle, with higher-income countries spending more and lower-income countries less.

(Reporting by Giulia Segreti. Editing by Maria Pia Quaglia and Gerry Doyle)

all right reserved for yahoo news

PREV Judge approves $650M Facebook privacy lawsuit settlement
NEXT Covid's lost generation: Devastating report lays bare the £350bn toll on ...